Cargando…

Potentiation of temozolomide and BCNU cytotoxicity by O(6)-benzylguanine: a comparative study in vitro.

Depletion of the DNA repair protein O(6)-alkylguanine-DNA alkyltransferase (AGT) with O(6)-benzylguanine (O(6)-BG) has been widely shown to enhance 1,3-bis(2-chloroethyl)-nitrosourea (BCNU) activity. This study aimed to determine whether temozolomide, a methylating imidazotetrazinone, would similarl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wedge, S. R., Porteus, J. K., May, B. L., Newlands, E. S.
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1996
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2074446/ https://www.ncbi.nlm.nih.gov/pubmed/8595163

Ejemplares similares

O6-benzylguanine enhances the sensitivity of a glioma xenograft with low O6-alkylguanine-DNA alkyltransferase activity to temozolomide and BCNU.
por: Wedge, S. R., et al.
Publicado: (1996)

3-aminobenzamide and/or O6-benzylguanine evaluated as an adjuvant to temozolomide or BCNU treatment in cell lines of variable mismatch repair status and O6-alkylguanine-DNA alkyltransferase activity.
por: Wedge, S. R., et al.
Publicado: (1996)

Factorial Design as a Tool for the Optimization of PLGA Nanoparticles for the Co-Delivery of Temozolomide and O6-Benzylguanine
por: Ramalho, Maria João, et al.
Publicado: (2019)

Redox-Responsive Magnetic Nanoparticle for Targeted Convection-Enhanced Delivery of O(6)-Benzylguanine to Brain Tumors
por: Stephen, Zachary R., et al.
Publicado: (2014)

In vitro potentiation of BCNU activity in rat brain tumour cells pretreated with misonidazole.
por: Siemann, D. W., et al.
Publicado: (1984)

Inhibitors of GLUT/SLC2A Enhance the Action of BCNU and Temozolomide against High-Grade Gliomas
por: Azzalin, Alberto, et al.
Publicado: (2017)

In vivo Selection of Autologous MGMT Gene-Modified Cells Following Reduced Intensity Conditioning with BCNU and Temozolomide in the Dog Model
por: Gori, Jennifer L., et al.
Publicado: (2012)

O6-methylguanine-DNA methyltransferase in pretreatment tumour biopsies as a predictor of response to temozolomide in melanoma.
por: Middleton, M. R., et al.
Publicado: (1998)

Depletion of O6-alkylguanine-DNA alkyltransferase correlates with potentiation of temozolomide and CCNU toxicity in human tumour cells.
por: Baer, J. C., et al.
Publicado: (1993)

Enhanced anti-tumour activity of carmustine (BCNU) with tumour necrosis factor in vitro and in vivo.
por: Jones, A. L., et al.
Publicado: (1990)

Vidarabin-monophosphate, BCNU, VM26--an in vitro comparative study of active agents in the treatment of malignant human brain tumours.
por: Bogdahn, U., et al.
Publicado: (1987)

Is Interstitial Chemotherapy with Carmustine (BCNU) Wafers Effective against Local Recurrence of Glioblastoma? A Pharmacokinetic Study by Measurement of BCNU in the Tumor Resection Cavity
por: Ohnishi, Takanori, et al.
Publicado: (2022)

Unraveling the cytotoxic potential of Temozolomide loaded into PLGA nanoparticles
por: Jain, Darshana S, et al.
Publicado: (2014)

Safety and efficacy of carmustine (BCNU) wafers for metastatic brain tumors
por: Ene, Chibawanye I., et al.
Publicado: (2016)

New insights into estrogenic regulation of O(6)-methylguanine DNA-methyltransferase (MGMT) in human breast cancer cells: Co-degradation of ER-α and MGMT proteins by fulvestrant or O(6)-benzylguanine indicates fresh avenues for therapy
por: Paranjpe, Ameya, et al.
Publicado: (2016)

In vivo response of KHT sarcomas to combination chemotherapy with radiosensitizers and BCNU.
por: Mulcahy, R. T., et al.
Publicado: (1981)

BCNU for recurrent glioblastoma multiforme: efficacy, toxicity and prognostic factors
por: Reithmeier, Thomas, et al.
Publicado: (2010)

Potentiation of temozolomide-induced cytotoxicity: a comparative study of the biological effects of poly(ADP-ribose) polymerase inhibitors.
por: Boulton, S., et al.
Publicado: (1995)

Click Chemistry-Generated Auristatin F–Linker–Benzylguanine for a SNAP-Tag-Based Recombinant Antibody–Drug Conjugate Demonstrating Selective Cytotoxicity toward EGFR-Overexpressing Tumor Cells
por: Huysamen, Allan M., et al.
Publicado: (2023)

In vivo interaction of anti-cancer drugs with misonidazole or metronidazole: cyclophosphamide and BCNU.
por: Tannock, I. F.
Publicado: (1980)

Interstitial chemotherapy with biodegradable BCNU (Gliadel(®)) wafers in the treatment of malignant gliomas
por: Bota, Daniela A, et al.
Publicado: (2007)

Symptomatic Remote Cyst after BCNU Wafer Implantation for Malignant Glioma
por: MATSUMURA, Hideaki, et al.
Publicado: (2018)

Importance of biomarkers in glioblastomas patients receiving local BCNU wafer chemotherapy
por: Urbschat, Steffi, et al.
Publicado: (2017)

Influence of O(6)-benzylguanine on the anti-tumour activity and normal tissue toxicity of 1,3-bis(2-chloroethyl)-1-nitrosourea and molecular combinations of 5-fluorouracil and 2-chloroethyl-1-nitrosourea in mice
por: Bibby, M C, et al.
Publicado: (1999)

A randomized phase III study comparing dacarbazine, BCNU, cisplatin and tamoxifen with dacarbazine and interferon in advanced melanoma
por: Middleton, M R, et al.
Publicado: (2000)

Daunorubicin and doxorubicin but not BCNU have deleterious effects on organotypic multicellular spheroids of gliomas.
por: Kaaijk, P., et al.
Publicado: (1996)

rhGM-CSF ameliorates neutropenia in patients with malignant glioma treated with BCNU.
por: Rampling, R., et al.
Publicado: (1994)

MLTI-11. IMPLANTABLE POLYMERIC BCNU AS AN ADJUNCT TO SURGERY FOR METASTATIC INTRACRANIAL DISEASE
por: Ryken, Timothy, et al.
Publicado: (2019)

Withdrawn: In vitro single‐strand DNA damage and cancer cell cytotoxicity of temozolomide
Publicado: (2019)

High dose melphalan, BCNU and etoposide with autologous bone marrow transplantation for Hodgkin's disease.
por: Zulian, G. B., et al.
Publicado: (1989)

Superoxide Enhances the Antitumor Combination of AdMnSOD Plus BCNU in Breast Cancer
por: Sun, Wenqing G., et al.
Publicado: (2010)

Advanced Gastric Carcinoma Chemotherapy with Cisplatin, Mitomycin C, BCNU, and 5-Fluorouracil in Combination
por: Kim, Re Hwe, et al.
Publicado: (1987)

STMO-15 THE CLINICAL IMPACT OF VENTRICULAR OPENING IN THE IMPLANTATION OF BCNU WAFERS FOR MALIGNANT GLIOMA
por: Matsuda, Ryosuke, et al.
Publicado: (2022)

Anticancer Potential of Temozolomide-Loaded Eudragit-Chitosan Coated Selenium Nanoparticles: In Vitro Evaluation of Cytotoxicity, Apoptosis and Gene Regulation
por: Mazarei, Madineh, et al.
Publicado: (2021)

Depletion of Kruppel-like factor 15 sensitized gliomas to temozolomide cytotoxicity through O(6)-methylguanine-DNA methyl-transferase
por: Qu, Xinjuan, et al.
Publicado: (2021)

Successful immunotherapy with micrococcus, BCG or related polysaccharides on L1210 leukaemia after BCNU chemotherapy.
por: Verloes, R., et al.
Publicado: (1981)

Chemotherapy with BCNU in recurrent glioma: Analysis of clinical outcome and side effects in chemotherapy-naïve patients
por: Jungk, Christine, et al.
Publicado: (2016)

TB-04 TERT PROMOTER MUTATION AS A SUSCEPTIBLE MOLECULAR MARKER OF BCNU LOCAL THERAPY
por: Miyake, Shigeta, et al.
Publicado: (2019)

STMO-01 Cerebral edema and perioperative epilepsy due to placement of BCNU wafer for malignant glioma
por: Fujii, Yu, et al.
Publicado: (2020)

Methadone Potentiates the Cytotoxicity of Temozolomide by Impairing Calcium Homeostasis and Dysregulation of PARP in Glioblastoma Cells
por: Honc, Ondrej, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nd6rfkdfvd7om0ce11hqo42k7k